What adjustments can be made to the medication regimen of a patient with mood instability and trauma exposure, taking Abilify (aripiprazole) 5mg, Buspar (buspirone) 7.5mg twice daily, and hydroxyzine?

Medication Regimen Adjustment for Mood Instability and Trauma Exposure

Direct Recommendation

Increase aripiprazole from 5mg to 10mg daily, continue buspirone 7.5mg twice daily, discontinue hydroxyzine due to excessive sedation, and add mirtazapine 15mg at bedtime for sleep and additional mood stabilization. 1, 2, 3

---

Evidence-Based Rationale for Each Adjustment

Aripiprazole Dose Increase (5mg → 10mg)

• The American Academy of Child and Adolescent Psychiatry recommends aripiprazole at 10mg daily as the target therapeutic dose for mood stabilization in bipolar disorder, with the FDA label indicating that 10mg is the standard maintenance dose. 1, 3

• Aripiprazole has demonstrated efficacy in trauma-exposed populations, with studies showing significant improvements in PTSD symptoms, anxiety, and mood instability at doses ranging from 10-15mg daily. 4

• The current 5mg dose is subtherapeutic for most patients with mood instability—titration to 10mg provides optimal dopamine partial agonist activity for mood stabilization without excessive activation. 3

• Aripiprazole specifically improved irritability, dysphoria, anxiety, and insomnia in a trauma-exposed patient with brain injury, supporting its use in trauma-related mood instability. 5

Buspirone Continuation (7.5mg BID)

• Buspirone at 7.5mg twice daily (15mg total) represents a reasonable starting dose, though the American Academy of Family Physicians notes that most patients require 20-60mg daily for full anxiolytic efficacy. 2, 6

• Buspirone has demonstrated efficacy in PTSD, improving anxiety, insomnia, flashbacks, and depressed mood with onset of clinical benefit ranging from 5-29 days. 7

• Continue the current dose initially while optimizing aripiprazole; reassess in 4 weeks and consider increasing to 10mg three times daily (30mg total) if anxiety symptoms persist, as buspirone requires 2-4 weeks at therapeutic doses to demonstrate full anxiolytic effects. 2, 6

• Buspirone has minimal drug interactions with aripiprazole and mirtazapine, making it safe to continue in this combination regimen. 6

Hydroxyzine Discontinuation

• Hydroxyzine causes excessive sedation in this patient and should be discontinued immediately—while it showed superiority over placebo for generalized anxiety in controlled trials, the high risk of bias in these studies and the availability of better-tolerated alternatives make it inappropriate when sedation is problematic. 8

• The Cochrane review concluded that despite some efficacy, hydroxyzine cannot be recommended as a reliable first-line treatment due to methodological limitations and its side effect profile, particularly drowsiness. 8

• Discontinue hydroxyzine abruptly (no taper needed for antihistamines) and replace its anxiolytic function with optimized buspirone dosing and the addition of mirtazapine. 8

Mirtazapine Addition (15mg at bedtime)

• Mirtazapine 15-30mg at bedtime provides sedation for insomnia while offering additional anxiolytic and antidepressant effects, making it an evidence-based replacement for hydroxyzine that addresses multiple symptom domains simultaneously. 2

• The American Academy of Family Physicians recognizes mirtazapine as superior to sedating antihistamines because it provides therapeutic benefit beyond sedation, including noradrenergic and serotonergic modulation for mood and anxiety. 2

• Start mirtazapine at 15mg at bedtime; this dose provides maximal sedation (higher doses are paradoxically less sedating due to increased noradrenergic activity). 2

• Mirtazapine has no significant drug interactions with aripiprazole or buspirone, and its sedating effects will address the sleep disturbance component of this patient's presentation. 2

---

Implementation Algorithm

Week 1-2: Initial Adjustments

• Day 1: Discontinue hydroxyzine immediately (no taper required). 8
• Day 1: Increase aripiprazole from 5mg to 10mg daily (can be taken morning or evening, without regard to meals). 3
• Day 1: Start mirtazapine 15mg at bedtime. 2
• Day 1: Continue buspirone 7.5mg twice daily unchanged. 6

Week 2-4: Monitoring Phase

• Assess for mood stabilization, reduced anxiety, improved sleep, and tolerability of the new regimen. 1, 2
• Monitor for aripiprazole-related akathisia or restlessness (most common side effects at 10mg dose). 4
• Monitor for mirtazapine-related weight gain or excessive morning sedation. 2

Week 4-6: Optimization Phase

• If anxiety symptoms persist despite mood improvement: Increase buspirone to 10mg three times daily (30mg total) over 2-3 weeks, as most patients require at least 30mg daily for full anxiolytic efficacy. 2, 6
• If sleep remains problematic: Consider increasing mirtazapine to 30mg at bedtime (though 15mg is often more sedating). 2
• If mood instability persists: Consider adding a formal mood stabilizer (lithium or valproate) rather than further increasing aripiprazole beyond 10mg. 1

---

Critical Monitoring Parameters

Metabolic Monitoring for Aripiprazole

• Obtain baseline body mass index, waist circumference, blood pressure, fasting glucose, and fasting lipid panel before starting or increasing aripiprazole. 1
• Monitor BMI monthly for 3 months, then quarterly; monitor blood pressure, glucose, and lipids at 3 months, then yearly. 1

Mirtazapine-Specific Monitoring

• Monitor for weight gain at each visit (common side effect that may be problematic in some patients). 2
• Assess for morning sedation or "hangover" effect that may interfere with daytime functioning. 2

Buspirone Optimization Monitoring

• Reassess anxiety symptoms at 4 weeks on current dose before concluding that buspirone is ineffective—it requires 2-4 weeks at therapeutic doses for full benefit. 2, 6

---

Common Pitfalls to Avoid

Premature Discontinuation of Buspirone

• Do not discontinue buspirone prematurely—it requires 2-4 weeks at therapeutic doses (typically 30mg daily) to demonstrate full anxiolytic effects, and many clinicians abandon it before reaching adequate dosing. 2, 6

Aripiprazole Akathisia Management

• If akathisia develops with aripiprazole 10mg, add propranolol 10-20mg twice daily rather than reducing the aripiprazole dose, as 10mg is the target therapeutic dose for mood stabilization. 1, 3

Mirtazapine Dosing Paradox

• Remember that mirtazapine is MORE sedating at 15mg than at 30-45mg due to differential receptor binding—if sedation is insufficient at 15mg, do not automatically increase the dose. 2

Polypharmacy Without Clear Rationale

• This regimen (aripiprazole + buspirone + mirtazapine) represents rational polypharmacy with each agent targeting distinct symptom domains: aripiprazole for mood stabilization, buspirone for anxiety, and mirtazapine for sleep and additional mood/anxiety support. 1, 2

Ignoring Psychosocial Interventions

• Cognitive-behavioral therapy should be strongly recommended as combination therapy with medication shows superior outcomes to either alone for both mood instability and trauma-related symptoms. 9, 2

---

Expected Timeline for Response

• Mirtazapine: Sleep improvement within 1-3 days; mood/anxiety benefits emerge over 2-4 weeks. 2
• Aripiprazole: Initial mood stabilization within 1-2 weeks; full therapeutic effect by 4-6 weeks at 10mg. 3, 4
• Buspirone: Anxiety reduction begins at 2-4 weeks; maximal benefit at 4-6 weeks on therapeutic dose. 2, 6, 7